or
forgot password
  • cancer clinical trials in charlotte, NC

  • Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
    Presbyterian Hospital

    Trial Locations
    Presbyterian Hospital
    Carolinas Medical Center/Levine Cancer Institute
    Lymphoma
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Lymphoma
    Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
    Blumenthal Cancer Center
    Charlotte, North Carolina 28203
    Non-small Cell Lung Cancer
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Leukemia
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Blumenthal Cancer Center
    Charlotte, North Carolina 28203
    Ovarian Cancer
    A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
    Presbyterian Blume Pediatric Hematology-Oncology Clinic
    Charlotte, North Carolina 28204
    Sickle Cell Anemia, Sickle ß0-Thalassemia
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
    Carolinas Rehabilitation
    Charlotte, North Carolina
    Lymphedema
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Dysphagia, Lung Cancer, Pain, Esophagitis
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    BKM120 as Second-line Therapy for Advanced Endometrial Cancer
    Carolinas HealthCare Systems Blumenthal Cancer Center
    Charlotte, North Carolina 28207
    Advanced Endometrial Cancer
    Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
    Carolina Medical Center
    Charlotte, North Carolina 28203
    Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    Carolinas HealthCare System
    Charlotte, North Carolina
    Colorectal Cancer Metastatic
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Carolinas Research Associates

    Trial Locations
    Carolinas Research Associates
    American Health Research
    Overactive Bladder